论文信息 - The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent - 字舞流文

The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent

Q. Ding | Z. Fang | Zu-quan Xiong | S. Zhong | Zhoujun Shen | Shanwen Chen | Yishuo Wu | Y. Zang | L. Zou | Shenghua Liu | Zuquan Xiong | Shan Zhong